Optimized low-dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment.
Zoetemelk M, Ramzy GM, Rausch M, Koessler T, van Beijnum JR, Weiss A, Mieville V, Piersma SR, de Haas RR, Delucinge-Vivier C, Andres A, Toso C, Henneman AA, Ragusa S, Petrova TV, Docquier M, McKee TA, Jimenez CR, Daali Y, Griffioen AW, Rubbia-Brandt L, Dietrich PY, Nowak-Sliwinska P.
Zoetemelk M, et al.
Mol Oncol. 2020 Nov;14(11):2894-2919. doi: 10.1002/1878-0261.12797. Epub 2020 Oct 5.
Mol Oncol. 2020.
PMID: 33021054
Free PMC article.